$AIXN
AiXin Life International, Inc. Stock $aixn

$aixn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223019866 Filed on June 02, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$754.7K	$1.196M	$418.7K
YoY Change	80.26%	70.3%	-40.03%
Cost Of Revenue	$653.3K	$1.015M	$636.1K
YoY Change	2.69%	51.93%	368.92%
Gross Profit	$101.4K	$181.1K	-$217.5K
YoY Change	-146.64%	428.77%	-138.66%
Gross Profit Margin	13.44%	15.14%	-51.94%
Selling, General & Admin	$604.3K	$705.2K	$554.7K
YoY Change	8.95%	7.12%	62.99%
% of Gross Profit	595.81%	389.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$104.6K	$102.7K	$29.64K
YoY Change	252.77%	38.34%	309.96%
% of Gross Profit	103.09%	56.7%
Operating Expenses	$1.307M	$705.2K	$554.7K
YoY Change	135.57%	7.12%	62.99%
Operating Profit	-$552.0K	-$524.2K	-$772.2K
YoY Change	-28.52%	-16.01%	-447.55%
Interest Expense	$290.00	$1.240K	$1.330K
YoY Change	-78.2%	20.39%	9.02%
% of Operating Profit
Other Income/Expense, Net	$22.64K	$7.990K	$19.24K
YoY Change	17.69%	-49.21%	-1238.46%
Pretax Income	-$529.3K	-$514.9K	-$751.6K
YoY Change	-29.57%	-15.22%	-439.01%
Income Tax	$457.00	$450.00	$490.00
% Of Pretax Income
Net Earnings	-$529.8K	-$515.4K	-$752.1K
YoY Change	-29.56%	-12.58%	-439.23%
Net Earnings / Revenue	-70.2%	-43.08%	-179.63%
Basic Earnings Per Share	-$0.02		-$0.03
Diluted Earnings Per Share	-$0.02	-$0.02	-$15.04K
COMMON SHARES
Basic Shares Outstanding	25.00M shares	50.00M shares	25.00M shares
Diluted Shares Outstanding	25.00M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$496.9K	$510.1K	$8.590M
YoY Change	-94.21%	-94.04%	12.45%
Cash & Equivalents	$496.9K	$510.1K	$8.590M
Short-Term Investments
Other Short-Term Assets	$198.9K	$213.7K	$381.7K
YoY Change	-47.9%	237.71%	142.59%
Inventory	$683.0K	$499.3K	$253.6K
Prepaid Expenses
Receivables	$431.9K	$562.6K	$70.95K
Other Receivables	$102.0K	$83.10K	$28.20K
Total Short-Term Assets	$2.027M	$1.976M	$9.324M
YoY Change	-78.27%	-78.53%	16.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.878M	$1.972M	$1.965M
YoY Change	-4.42%	579.58%	1541.84%
Goodwill
YoY Change
Intangibles	$1.092K	$1.269K
YoY Change		-34.59%
Long-Term Investments	$87.37K	$86.99K	$94.65K
YoY Change	-7.69%	-7.6%
Other Assets	$15.17K	$15.56K	$18.40K
YoY Change	-17.55%	-17.23%
Total Long-Term Assets	$2.793M	$3.075M	$2.079M
YoY Change	34.31%	25.26%	1637.38%
TOTAL ASSETS
Total Short-Term Assets	$2.027M	$1.976M	$9.324M
Total Long-Term Assets	$2.793M	$3.075M	$2.079M
Total Assets	$4.819M	$5.051M	$11.40M
YoY Change	-57.74%	-56.68%	40.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$440.2K	$398.5K	$410.9K
YoY Change	7.15%	-1.89%	954.59%
Accrued Expenses	$2.917M	$3.156M	$1.669M
YoY Change	74.81%	102.44%	222.33%
Deferred Revenue
YoY Change
Short-Term Debt	$87.37K	$86.99K	$94.65K
YoY Change	-7.69%	-7.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.398M	$5.322M	$5.117M
YoY Change	5.49%	19.55%	469.03%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$179.6K	$194.7K	$844.0K
YoY Change	-78.72%	-82.9%	3377.42%
Total Long-Term Liabilities	$179.6K	$194.7K	$844.0K
YoY Change	-78.72%	-82.9%	3377.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.398M	$5.322M	$5.117M
Total Long-Term Liabilities	$179.6K	$194.7K	$844.0K
Total Liabilities	$5.578M	$5.517M	$5.961M
YoY Change	-6.44%	-1.32%	545.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.66M	-$15.25M
YoY Change		71.72%
Common Stock	$250.00	$250.00
YoY Change		-50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$758.4K	-$466.2K	$5.442M
YoY Change
Total Liabilities & Shareholders Equity	$4.819M	$5.051M	$11.40M
YoY Change	-57.74%	-56.68%	40.82%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$529.8K	-$515.4K	-$752.1K
YoY Change	-29.56%	-12.58%	-439.23%
Depreciation, Depletion And Amortization	$104.6K	$102.7K	$29.64K
YoY Change	252.77%	38.34%	309.96%
Cash From Operating Activities	-$472.7K	-$212.0K	-$503.5K
YoY Change	-6.12%	-64.89%	-454.99%
INVESTING ACTIVITIES
Capital Expenditures	$1.746K	$104.2K
YoY Change		-7878.36%
Acquisitions
YoY Change
Other Investing Activities	-$3.440K	-$3.812M
YoY Change		19299.64%
Cash From Investing Activities	-$5.181K	-$3.916M
YoY Change		18557.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$437.6K	-863.7K	504.6K
YoY Change	-13.29%	-114.85%	-439.2%
NET CHANGE
Cash From Operating Activities	-$472.7K	-212.0K	-503.5K
Cash From Investing Activities	-$5.181K	-3.916M
Cash From Financing Activities	$437.6K	-863.7K	504.6K
Net Change In Cash	-$37.47K	-4.992M	1.110K
YoY Change	-3475.32%	-196.19%	-116.02%
FREE CASH FLOW
Cash From Operating Activities	-$472.7K	-$212.0K	-$503.5K
Capital Expenditures	$1.746K	$104.2K
Free Cash Flow	-$474.4K	-$316.3K	-$503.5K
YoY Change	-5.78%	-47.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000835662
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Other Receivable After Allowance For Credit Loss Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q1	AIXN	Accounts Payable Related Party Current AccountsPayableRelatedPartyCurrent		usd
CY2023Q1	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve		usd
CY2022Q1	AIXN	Increase Decrease In Accounts Payable Related Party IncreaseDecreaseInAccountsPayableRelatedParty		usd
CY2022Q1	AIXN	Cash Disposed At Disposal Of Subsidiary CashDisposedAtDisposalOfSubsidiary		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-17284
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AIXIN LIFE INTERNATIONAL, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1085935
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Hongxing International Business Building 2, 14th FL
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 69 Qingyun South Ave.
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jinjiang District
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Chengdu City
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CN
CY2023Q1	dei	City Area Code CityAreaCode	86
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	313-6732526
CY2023Q1	dei	Security12g Title Security12gTitle	Common Stock, $0.00001 Par Value
CY2023Q1	dei	Trading Symbol TradingSymbol	AIXN
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24999842	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	496918	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510128	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	85516	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	109772	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	431927	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	562581	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73653	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42631	usd
CY2023Q1	us-gaap	Supplies Supplies	153542	usd
CY2022Q4	us-gaap	Supplies Supplies	168523	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	683035	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	499252	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	101979	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83102	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2026570	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1975989	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1878012	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1971793	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1092	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1269	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15168	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15556	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	87367	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	86992	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	811021	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	999285	usd
CY2023Q1	us-gaap	Assets Assets	4819230	usd
CY2022Q4	us-gaap	Assets Assets	5050884	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	440237	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	398469	usd
CY2022Q4	AIXN	Accounts Payable Related Party Current AccountsPayableRelatedPartyCurrent	165958	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	332084	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	139502	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	44583	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	104100	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2232267	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2356490	usd
CY2023Q1	AIXN	Government Grant GovernmentGrant	954467	usd
CY2022Q4	AIXN	Government Grant GovernmentGrant	950371	usd
CY2023Q1	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	87367	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	86992	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	748331	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	883583	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	558648	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236882	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5397984	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5322347	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	179631	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194725	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5577615	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5517072	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24999842	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24999842	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	250	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	250	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14551468	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14458583	usd
CY2023Q1	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2022Q4	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15659482	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15249858	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	197391	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	172849	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-758385	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-466188	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4819230	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5050884	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	754713	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418678	usd
CY2023Q1	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	175488	usd
CY2022Q1	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	124524	usd
CY2023Q1	AIXN	Hotel Operating Costs HotelOperatingCosts	477794	usd
CY2022Q1	AIXN	Hotel Operating Costs HotelOperatingCosts	511619	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	191273	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	189586	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	413059	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	244796	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-43816	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27422	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92885	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92885	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1306683	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1190832	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-551970	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-772154	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	289	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1328	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	24861	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	19434	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2507	usd
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	197	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	22643	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20565	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-529327	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-751589	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	492	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-529784	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-752081	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24542	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31864	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-505242	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-720217	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.021
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.030
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-466188	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2023Q1	AIXN	Disposal Of Subsidiary DisposalOfSubsidiary	120160	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-529784	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24542	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-758385	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6069491	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6069491	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-752081	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31864	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5442159	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5442159	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-529784	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-752081	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	104561	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29639	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-43816	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	27422	usd
CY2023Q1	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve	18502	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	210334	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	229242	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2023Q1	AIXN	Changes In Deferred Tax Asset ChangesInDeferredTaxAsset	457	usd
CY2022Q1	AIXN	Changes In Deferred Tax Asset ChangesInDeferredTaxAsset	492	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-176944	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	52174	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	50416	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6811	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	49587	usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	9416	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	200787	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18875	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	42332	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2564	usd
CY2023Q1	AIXN	Increase Decrease In Accounts Payable Related Party IncreaseDecreaseInAccountsPayableRelatedParty	-167209	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	192689	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	12940	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-59279	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	593	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	186473	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	203673	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-123208	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	124901	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-472681	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-503520	usd
CY2023Q1	AIXN	Cash Disposed At Disposal Of Subsidiary CashDisposedAtDisposalOfSubsidiary	-3435	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1746	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5181	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	437560	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	504629	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	437560	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	504629	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2836	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	46373	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-37466	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47482	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	619900	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8600853	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	582434	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8648335	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 2 reverse stock split
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-551970	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-772154	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-472681	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-503520	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15659482	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510128	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	496918	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_z4CnuPAUDosa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zY5GwpnVFIg7">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z09IWtAXDNF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zCrYMdSLAJKd">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Depreciation Depreciation	28978	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	230076	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	272550	usd
CY2023Q1	AIXN	Schedule Of Accounts Receivable Allowance For Doubtful Accounts ScheduleOfAccountsReceivableAllowanceForDoubtfulAccounts	<p id="xdx_89C_ecustom--ScheduleOfAccountsReceivableAllowanceForDoubtfulAccounts_zhfA6s0iBEN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the three months ended March 31, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zKJG9JmHM5xa" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_495_20230101__20230331__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_zOM3RUTmIDnk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49E_20220101__20220331__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_z8OSghtoOb16" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months ended March 31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z7XcOKRfEfjl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Beginning balance</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">272,550</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">213,787</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eus-gaap--ProvisionForDoubtfulAccounts_zYEkrBP5XLF1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provisions for bad debt</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0561">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,422</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_iN_di_z7Aq7ZSyDIWc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Recoveries/Write offs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(43,816</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_iN_di_zp6jDXFlqcc7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Effect of translation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,342</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,181</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_ziVppCwEr8g3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">230,076</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">242,390</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table>
CY2023Q1	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve	18502	usd
CY2023Q1	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
CY2023Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_84C_eus-gaap--RevenueRecognitionDeferredRevenue_zyyMLE2GZ7P3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z4dO6Xo51IB2">Unearned Revenue</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s unearned revenue primarily consists of advances received from customers for the purchase of products prior to the delivery of goods, and for the rental of hotel rooms prior to the delivery of service. The delivery of products and room rental services is (normally within one year) based upon contract terms and customer demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	24999842	shares
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zXg2xldybWO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zxMqadjQ2m9h">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB <span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uRMB_c20230331_zqB7wVllPvAa">500,000</span> ($<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uUSD_c20230331_zb3QifGklDNf" title="Cash FDIC insured amount">72,500</span>) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company had no customer that accounted for over <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zplPv143bg4d"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z3FGkbfpL9kl">10</span></span>% of its total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company had two suppliers that accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zgmV6RhcyxF7">17</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_zRATYFYywH3e">15</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2022, the Company had no supplier that accounted for over <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoSupplierMember_zdrDwkjnrjhd" title="Concentration risk, percentage">10</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	72500	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	754713	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418678	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1306683	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1190832	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-551970	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-772154	usd
CY2023Q1	us-gaap	Assets Assets	4819230	usd
CY2022Q4	us-gaap	Assets Assets	5050884	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	579782	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2023Q1	us-gaap	Deposit Assets DepositAssets	13001	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	15546	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	38796	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	9490	usd
CY2023Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10268	usd
CY2022Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10124	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	11588	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7471	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	73653	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	42631	usd
CY2023Q1	us-gaap	Supplies Supplies	153542	usd
CY2022Q4	us-gaap	Supplies Supplies	168523	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	127896	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	62462	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2895	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	15315	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100772	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	521	usd
CY2023Q1	AIXN	Inventory Drugs Pharmaceutical And Nutritional Products Gross InventoryDrugsPharmaceuticalAndNutritionalProductsGross	469757	usd
CY2022Q4	AIXN	Inventory Drugs Pharmaceutical And Nutritional Products Gross InventoryDrugsPharmaceuticalAndNutritionalProductsGross	412129	usd
CY2023Q1	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	74294	usd
CY2022Q4	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	82646	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	775614	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	573073	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	92579	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	73821	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	683035	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	499252	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2942707	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2928342	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1064695	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	956549	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1878012	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1971793	usd
CY2023Q1	us-gaap	Depreciation Depreciation	104400	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8601	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8564	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7509	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7295	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1092	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1269	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	161	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	661	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	44583	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	104100	usd
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	266690	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	270349	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	309903	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	307331	usd
CY2023Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	30107	usd
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	32746	usd
CY2023Q1	us-gaap	Construction Payable Current ConstructionPayableCurrent	1363366	usd
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	1384674	usd
CY2023Q1	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	26833	usd
CY2022Q4	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	32278	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	160648	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	233894	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	11357	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	11308	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	63363	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	83910	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2232267	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2356490	usd
CY2023Q1	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	87367	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	86992	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	811021	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	999285	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	748331	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	883583	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	179631	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194725	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	927962	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1078308	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	210334	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	229242	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	186473	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	203673	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M9D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M9D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	729243	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	136646	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	62162	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23986	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	952037	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24075	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	927962	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	748331	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	179631	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	101979	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83102	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	101979	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83102	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	558648	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236882	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	558648	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236882	usd
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	5000
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	789	usd
CY2014Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-05-28
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2020Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one (1)-for-four (4) reverse stock
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	AIXN	Net Income Transfer Percentage NetIncomeTransferPercentage	0.10	pure
CY2023Q1	AIXN	Capital Reserve Percentage CapitalReservePercentage	0.50	pure
CY2023Q1	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
CY2022Q1	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
CY2023Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_802_eus-gaap--LossContingencyDisclosures_z5vYPmnbSvg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16. <span id="xdx_820_zpyXYEDmJvL3">OPERATING CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Litigation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $<span id="xdx_90B_eus-gaap--LongTermPurchaseCommitmentAmount_uUSD_c20201201__20201231__us-gaap--GuaranteeObligationsByNatureAxis__us-gaap--IndemnificationGuaranteeMember_zt7yL2LhxES" title="Purchase commitment amount">392,305</span> (RMB <span id="xdx_904_eus-gaap--LongTermPurchaseCommitmentAmount_uRMB_c20201201__20201231__us-gaap--GuaranteeObligationsByNatureAxis__us-gaap--IndemnificationGuaranteeMember_zmbtw9nS7k8d" title="Purchase commitment amount">2,500,000</span>) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $<span id="xdx_905_eus-gaap--LitigationSettlementExpense_uUSD_c20201201__20201231_z1yYsu4G5Sjb" title="Litigation settlement expense">392,305</span> (RMB <span id="xdx_902_eus-gaap--LitigationSettlementExpense_uRMB_c20201201__20201231_znnL6RXB50g8" title="Litigation settlement expense">2,500,000</span>) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	392305	usd
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2500000

Files In Submission

Name	View Source	Status
0001493152-23-019866-index-headers.html	Edgar Link	pending
0001493152-23-019866-index.html	Edgar Link	pending
0001493152-23-019866.txt	Edgar Link	pending
0001493152-23-019866-xbrl.zip	Edgar Link	pending
aixn-20230331.xsd	Edgar Link	pending
aixn-20230331_def.xml	Edgar Link	unprocessable
aixn-20230331_cal.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
aixn-20230331_pre.xml	Edgar Link	unprocessable
aixn-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIXN
AiXin Life International, Inc. Stock $aixn

2023 Q1 Form 10-Q Financial Statement

#000149315223019866 Filed on June 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN AiXin Life International, Inc. Stock $aixn

2023 Q1 Form 10-Q Financial Statement

#000149315223019866 Filed on June 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN
AiXin Life International, Inc. Stock $aixn